Company profile for Quell Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.Quell is focused on delivering therapies which are valued by physicians, ...
At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.Quell is focused on delivering therapies which are valued by physicians, patients and payors, which have the promise of delivering transformational results for our patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Translation & Innovation Hub 84 Wood Lane London
Telephone
Telephone
0207 096 9012
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/25/3174167/0/en/Quell-Therapeutics-to-Unveil-Promising-Data-for-QEL-005-a-Novel-CAR-Treg-Cell-Therapy-for-Complex-Autoimmune-Diseases-at-ACR-Convergence-2025.html

GLOBENEWSWIRE
25 Oct 2025

https://www.globenewswire.com/news-release/2025/08/27/3139858/0/en/Quell-Therapeutics-Establishes-World-Class-Scientific-Advisory-Board.html

GLOBENEWSWIRE
27 Aug 2025

https://www.globenewswire.com/news-release/2025/06/10/3096491/0/en/Quell-Therapeutics-Achieves-Key-Milestone-in-its-CAR-Treg-Cell-Therapy-Program-for-Inflammatory-Bowel-Disease.html

GLOBENEWSWIRE
10 Jun 2025

https://www.agcbio.com/news/agc-biologics-partners-with-quell-therapeutics-cell-therapy-cdmo-alliance-ind-submission-preparedness

PRESS RELEASE
17 May 2025

https://www.globenewswire.com/news-release/2024/11/18/2982494/0/en/Quell-Therapeutics-Achieves-Milestone-for-Type-1-Diabetes-CAR-Treg-Cell-Therapy-Program.html

GLOBENEWSWIRE
18 Nov 2024

https://www.globenewswire.com/news-release/2024/11/06/2975604/0/en/Quell-Therapeutics-to-Participate-at-Upcoming-Healthcare-Investor-Conferences.html

GLOBENEWSWIRE
06 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty